Clinical Trials Browser

Phase NA × Iodine-131 × Endocrine × Clear all

NCT04354324 2024-03-15

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Phase NA Recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary